Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07602257 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Investigating a Personalized Approach to Anti-Platelet Therapy

Study acronym: RAPID PREVENT
StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Jun 1, 2026 to Oct 1, 2026v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
RAPID PREVENT aims to identify if a personalized (targeted) anti-platelet strategy will reduce bleeding events when compared to the current standard anti-platelet therapy.
Trial Details
NCT Number NCT07602257
Lead Sponsor Ottawa Heart Institute Research Corporation
Conditions
(from sponsor)		 High Risk Bleeding
Related terms Thrombosis
Enrollment 1,760 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov